Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CollPlant Biotechnologies Q2 Adj. EPS $(0.23) Misses $(0.14) Estimate, Sales $179.000K Miss $2.544M Estimate

Author: Benzinga Newsdesk | August 20, 2025 06:01am
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.14) by 64.29 percent. This is a 30.3 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $179.000 thousand which missed the analyst consensus estimate of $2.544 million by 92.96 percent. This is a 28.11 percent decrease over sales of $249.000 thousand the same period last year.

Posted In: CLGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist